Close

Transition Therapeutics (TTHI) Says Lilly (LLY) Won't Advance TT401 into Phase 3

April 18, 2016 6:04 AM EDT Send to a Friend
Transition Therapeutics Inc. (Nasdaq: TTHI) announced that it has received notification that Eli Lilly and Co. ("Lilly") will not elect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login